Stock Market & Financial Investment News

News Breaks February 1, 2013 07:05 EDT BCR C.R. Bard downgraded to Sell from Underperform at CLSA CLSA downgraded CR Bard based on concerns its risk profile has increased with its new multi-year-plan following disappointing guidance. Price target lowered to $96 from $98. News For BCR From The Last 14 Days Check below for free stories on BCR the last two weeks. Sign up for a free trial to see the rest of the stories you've been missing. May 13, 2013 17:08 EDT BCR C.R. Bard to pay $48.26M to U.S to resolve false claims act accusations Subscribe for More Information May 8, 2013 07:38 EDT BCR BofA/Merrill's medical tech analyst hold an analyst/industry conference call Subscribe for More Information May 7, 2013 07:24 EDT BCR Mizuho Securities to host a conference Subscribe for More Information Sign up for a free trial to see the rest of the stories you've been missing.